Anyone in clinical trial with pasritamig, (T-cell engaging antibody)?

Posted by alperk @alperk, 5 days ago

anyone have experience with this clinical trial

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Johnson& Johnson describes pasritamig as a first-in-class bispecific T-cell-engaging antibody that shows potential in treating metastatic castration-resistant prostate cancer (mCRPC).

@alperk, which clinical trial involving pasritamig are you referring to? There are several listed here: https://www.cancer.gov/research/participate/clinical-trials/intervention/pasritamig

REPLY

The one being done at Florida Cancer Specialists in Sarasota monitored by their Fort Myers office

REPLY
Please sign in or register to post a reply.